Hengrui Medicine (01276.HK): The drug market approval application for SHR7280 tablets has been accepted by the National Medical Products Administration.

Zhtng Cijng APP information, Hengrui Medicine (01276.HK) announced that the company recently received a "Notice of Acceptance" issued by the National Medical Products Administration. The company's application for the market approval of SHR7280 tablets has been accepted by the National Medical Products Administration.